Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America, 104(34), 13780–13785.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: contaminated soil, clinical sources (wound, peritoneal - CCUG) and human faeces
DNA G+C(%): 31
|
Opt. T: 37℃
Low T(℃): 10(+)
Mid T(℃): 37(+)
NaCl 0.5-2%: 1-2(+)
Opt. pH: 7.5
pH 6.0-8.0: 6.0-8.0(+)
pH >8: 9(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: S(10; disc)
ampicillin: R(10; disc)
penicillin: S(10; disc)
|
|
gentamicin: R(10; disc)
kanamycin: R(30; disc)
neomycin: S(30; disc)
streptomycin: R(10; disc)
|
erythromycin: R(15; disc)
|
nalidixic-acid: S(30; disc)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
chlortetracycline: S(30; disc)
tetracycline: S(30; disc)
|
vancomycin: S(30; disc)
|
|
chloramphenicol: R(30; disc)
|
novobiocin: S(30; disc)
|